Antoine Lepillier1, Xavier Copie2, Gilles Lascault2, Olivier Paziaud2, Olivier Piot2. 1. Centre Cardiologique du Nord, 32, rue des Moulins Gémeaux, 93200, Saint-Denis, France. antoine.lepillier@yahoo.com. 2. Centre Cardiologique du Nord, 32, rue des Moulins Gémeaux, 93200, Saint-Denis, France.
Abstract
PURPOSE: Catheter radiofrequency ablation (RFA) is an effective treatment for symptomatic paroxysmal atrial fibrillation (AF). It has been demonstrated that the multielectrode pulmonary vein ablation catheter (PVAC) has favourable outcomes at 6-12 months post-ablation, but there are only few studies with a long-term follow-up. METHODS: We retrospectively reviewed 77 consecutive PVAC procedures in our centre, from November 2007 to December 2012. RFA was attempted in patients with symptomatic paroxysmal AF (mean age 58.7 ± 9.8 years, 50 men (64.9 %). The ablation strategy consisted of circumferential pulmonary vein isolation (CPVI) with the PVAC system. A questionnaire was used over the follow-up period to assess the efficacy of AF ablation. Success was defined as freedom from AF/atrial flutter or atrial arrhythmia for a period ranging from 3 to 12 months or more. RESULTS: Seventy-seven patients were included with paroxysmal AF. The mean duration of the procedure was 99.6 ± 26 min and fluoroscopy time 19.4 ± 6.8 min. Time of RFA was 22.4 ± 5.8 min. Acute complication rate was 10.4 % (the most frequent was vascular injury for 6 patients 7.8 %, 1 patient presented sepsis (1.3 %), 1 patient presented transient ischemic stroke). After a single procedure at a mean FU of 55 ± 11 months, 54/77 (70.1 %) patients were free of symptomatic AF. CONCLUSIONS: These long-term results suggest that PVAC is an efficient system for CPVI of symptomatic paroxysmal AF.
PURPOSE: Catheter radiofrequency ablation (RFA) is an effective treatment for symptomatic paroxysmal atrial fibrillation (AF). It has been demonstrated that the multielectrode pulmonary vein ablation catheter (PVAC) has favourable outcomes at 6-12 months post-ablation, but there are only few studies with a long-term follow-up. METHODS: We retrospectively reviewed 77 consecutive PVAC procedures in our centre, from November 2007 to December 2012. RFA was attempted in patients with symptomatic paroxysmal AF (mean age 58.7 ± 9.8 years, 50 men (64.9 %). The ablation strategy consisted of circumferential pulmonary vein isolation (CPVI) with the PVAC system. A questionnaire was used over the follow-up period to assess the efficacy of AF ablation. Success was defined as freedom from AF/atrial flutter or atrial arrhythmia for a period ranging from 3 to 12 months or more. RESULTS: Seventy-seven patients were included with paroxysmal AF. The mean duration of the procedure was 99.6 ± 26 min and fluoroscopy time 19.4 ± 6.8 min. Time of RFA was 22.4 ± 5.8 min. Acute complication rate was 10.4 % (the most frequent was vascular injury for 6 patients 7.8 %, 1 patient presented sepsis (1.3 %), 1 patient presented transient ischemic stroke). After a single procedure at a mean FU of 55 ± 11 months, 54/77 (70.1 %) patients were free of symptomatic AF. CONCLUSIONS: These long-term results suggest that PVAC is an efficient system for CPVI of symptomatic paroxysmal AF.
Authors: Pim Gal; Alissa E S M Aarntzen; Jaap Jan J Smit; Ahmet Adiyaman; Anand R Ramdat Misier; Peter Paul H M Delnoy; Arif Elvan Journal: Int J Cardiol Date: 2014-08-13 Impact factor: 4.164
Authors: Reza Wakili; Johannes Siebermair; Stephanie Fichtner; Moritz F Sinner; Eva Klocker; Lucia Olesch; Jan N Hilberath; Samira Sarai; Sebastian Clauss; Stefan Sattler; Stefan Kääb; Heidi L Estner Journal: Europace Date: 2016-01-11 Impact factor: 5.214
Authors: Christian von Bary; Stefan Weber; Christian Dornia; Christoph Eissnert; Claudia Fellner; Philipp Latzin; Sabine Fredersdorf; Stefan Stadler; Okka W Hamer Journal: Circ Arrhythm Electrophysiol Date: 2011-08-13
Authors: Fiorenzo Gaita; Domenico Caponi; Martina Pianelli; Marco Scaglione; Elisabetta Toso; Federico Cesarani; Carlo Boffano; Giovanni Gandini; Maria Consuelo Valentini; Roberto De Ponti; Franck Halimi; Jean François Leclercq Journal: Circulation Date: 2010-10-11 Impact factor: 29.690
Authors: M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty Journal: N Engl J Med Date: 1998-09-03 Impact factor: 91.245
Authors: Saagar Mahida; Darren A Hooks; Karin Nentwich; G Andre Ng; Massimo Grimaldi; Dong-In Shin; Nicolas Derval; Frederic Sacher; Benjamin Berte; Seigo Yamashita; Arnaud Denis; Mélèze Hocini; Thomas Deneke; Michel Haissaguerre; Pierre Jais Journal: J Cardiovasc Electrophysiol Date: 2015-06-16
Authors: Hakan Oral; Christoph Scharf; Aman Chugh; Burr Hall; Peter Cheung; Eric Good; Srikar Veerareddy; Frank Pelosi; Fred Morady Journal: Circulation Date: 2003-10-13 Impact factor: 29.690
Authors: John Hummel; Gregory Michaud; Robert Hoyt; David DeLurgio; Abdi Rasekh; Fred Kusumoto; Michael Giudici; Dan Dan; David Tschopp; Hugh Calkins; Lucas Boersma Journal: Heart Rhythm Date: 2013-11-14 Impact factor: 6.343
Authors: Giovanni Rovaris; Paolo De Filippo; Francesco Laurenzi; Gabriele Zanotto; Nicola Bottoni; Mattia Pozzi; Fabrizio Giofrè; Piergiuseppe De Girolamo; Emanuela Visentin; Elena Piazzi; Paola Ferrari Journal: J Interv Card Electrophysiol Date: 2017-09-05 Impact factor: 1.900